David C. Limburg - Concepedia

Concepedia

Author

David C. Limburg

Pfizer (United States)

Also Known As

D LIMBURG, D. Limburg, DAvid C. Limburg, David C Limburg, David C. Limburg, David Limburg, David C. Limburg

37

Publications

1.1K

Citations

15

H-Index

38

Concepts

All Affiliations

Pfizer (United States)Guilford College

DC

About

David C. Limburg is an author at Pfizer (United States) specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	609
2	Natural Sciences	9	9	281
3	Biochemistry	9	9	264
4	Engineering	3	3	140
5	Biomolecular Engineering	3	3	98

David C. Limburg

×

17

Publications

1.1K

Citations

15

H-Index

	Year	Citations
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life Jane L. Wang, David C. Limburg, Matthew J. Graneto, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel Benzopyran ClassFavorable Human Half-lifePharmacologyMechanism Of Action	2010	324
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of (( <i>S</i> )-2,2-Difluorocyclopropyl)((1 <i>R</i> ,5 <i>S</i> )-3-(2-((1-methyl-1 <i>H</i> -pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841) Andrew Fensome, Catherine M. Ambler, Eric P. Arnold, Journal of Medicinal Chemistry	2018	165
1-Cyanoimidazole as a Mild and Efficient Electrophilic Cyanating Agent Yong‐Qian Wu, David C. Limburg, Douglas E. Wilkinson, Organic Letters HeterocyclicCarbanion NucleophilesOrganic ElectrochemistryElectrosynthesisOrganic Chemistry	2000	94
Covalent Inhibitors of Interleukin-2 Inducible T Cell Kinase (Itk) with Nanomolar Potency in a Whole-Blood Assay Christoph W. Zapf, Brian S. Gerstenberger, Xing Li, Journal of Medicinal Chemistry	2012	77
A mild deprotection procedure for tert-butyl esters and tert-butyl ethers using ZnBr2 in methylene chloride Yong‐Qian Wu, David C. Limburg, Douglas E. Wilkinson, Tetrahedron Letters Chemical EngineeringTert-butyl EstersEngineeringMethylene ChlorideOrganic Chemistry	2000	64
Selective inducible microsomal prostaglandin E2 synthase-1 (mPGES-1) inhibitors derived from an oxicam template Jane Wang, David C. Limburg, Jeff Carter, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryBiochemistryOxicam TemplateMedicineNatural Sciences	2010	61
Synthesis of <i>N</i>-Glyoxyl Prolyl and Pipecolyl Amides and Thioesters and Evaluation of Their In Vitro and In Vivo Nerve Regenerative Effects Gregory S. Hamilton, Yong-Qian Wu, David C. Limburg, Journal of Medicinal Chemistry Drug TargetBioorganic ChemistrySmall Molecule LigandsChemical BiologyPharmaceutical Chemistry	2002	52
Automated Nanomole-Scale Reaction Screening toward Benzoate Bioisosteres: A Photocatalyzed Approach to Highly Elaborated Bicyclo[1.1.1]Pentanes James J. Mousseau, Matthew A. Perry, Mark W. Bundesmann, ACS Catalysis EngineeringBenzoate BioisosteresSynthetic PhotochemistryOrganic ChemistryChemistry	2021	42
The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part III: The three microdose candidates Jane L. Wang, Karl Aston, David C. Limburg, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryNovel Benzopyran ClassPharmaceutical ChemistryBiochemistryPart Iii	2010	36
Formation of nitrogen‐containing heterocycles using di(imidazole‐1‐yl)methanimine Yong‐Qian Wu, David C. Limburg, Douglas E. Wilkinson, Journal of Heterocyclic Chemistry Inorganic ChemistryChemical EngineeringEngineeringHeterocyclicHeterocyclic Compounds	2003	34

Page 1